Funded Tech Companies
Avidicure
Avidicure is a biopharmaceutical company, based in Oegstgeest. Investment was provided by BOM, BioGeneration Ventures and V-Bio Ventures.
Company Overview
Company Name
Avidicure
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
De Limes 7
Oegstgeest, 2342 DH
NL
Oegstgeest, 2342 DH
NL
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality, "AVC-Boosters", designed to safely deliver targeted and potent monotherapy, with broad applicability in oncology. AVC-Boosters unlock strong and orchestrated immunological responses, harnessing the full power of both the innate and adaptive immune system. The AVC-Booster design surpasses the best qualities of first-generation antibodies, checkpoint inhibitors, T-cell engagers and ADCs. The Company is based in the Netherlands and supported by a syndicate of top-tier investors led by EQT-Life Sciences, and with BioGeneration Ventures as founding investor.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/24/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arthur Lahr
Chief Operating Officer
Dirk Naeyer
Company Investors
Browse more funded tech companies:
Avidia | Avidimer Therapeutics
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs